| 摘要 |
An object of the present invention is the use of a compound of formula (I): or one of its pharmaceutically acceptable salts, for the manufacture of a medicament for the prevention and/or the treatment of metabolic syndrome and/or obesity and/or dyslipoproteinemia.
|
